Allergan plc (AGN)
(Delayed Data from NYSE)
$145.81 USD
+1.56 (1.08%)
Updated May 3, 2019 04:01 PM ET
After-Market: $145.88 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Earnings Yield (TTM)
The company's trailing twelve month (TTM) Earning Yield is used to determine whether the company is undervalued or overvalued. The Earning yield an indicator of the company's earnings and the price paid for the stock. The calculation is the inverse of the P/E ratio. The most common use of the Earnings ratio is to compare it to other stocks and to compare the yields to the 10 Year T-Bill. If earnings go up, the yield goes up. If earnings go down, so does the yield. For example: If the yield on the S&P 500 is greater than the 10 Year T-Bill, stocks would be considered undervalued.
AGN 145.81 +1.56(1.08%)
Will AGN be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for AGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AGN
Aurinia Completes Final Patient Treatment in Dry Eye Study
Satsuma Plunges on Disappointing Data on Migraine Treatment
AGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Coronavirus-Led Threats to MedTech That May Linger
Roche Acquires Stratos Genomics, Presents Data on NMOSD Drug
Intercept's (ICPT) Q1 Earnings and Revenues Beat Estimates
Other News for AGN
No Record found.